Camber Capital Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,250,000
Closed -$88.4M 35
2020
Q4
$88.4M Sell
4,250,000
-250,000
-6% -$4.66M 3.1% 15
2020
Q3
$69.9M Buy
+4,500,000
New +$77.5M 3.69% 8
2019
Q1
Sell
-1,000,000
Closed -$18.5M 30
2018
Q4
$18.5M Buy
+1,000,000
New +$23.8M 0.88% 31
2018
Q2
Sell
-1,500,000
Closed -$23.9M 34
2018
Q1
$23.9M Buy
+1,500,000
New +$27.9M 1.17% 26
2016
Q4
Sell
-1,271,500
Closed -$31.2M 37
2016
Q3
$31.2M Sell
1,271,500
-384,500
-23% -$9.95M 1.37% 21
2016
Q2
$33.4M Sell
1,656,000
-344,000
-17% -$9.74M 1.61% 27
2016
Q1
$52.6M Buy
+2,000,000
New +$148M 3.08% 14

Other funds holding BHC

Camber Capital Management's BHC Position: Q1 2021 in Review

Camber Capital Management sold out of Bausch Health (BHC) in Q1 2021, closing a stake of 4,250,000 shares — an estimated $88.4M sold.

Camber Capital Management first reported a position in BHC in Q1 2016 and held it in 7 quarters. The position peaked at $88.4M in Q4 2020. 352 funds tracked by Wall St. Rank hold BHC as of Q1 2021.

  • Camber Capital Management reported no remaining Bausch Health position as of Q1 2021 after selling out during the quarter.
  • Camber Capital Management sold 4,250,000 Bausch Health shares in Q1 2021, an estimated $88.4M.
  • Camber Capital Management first reported a position in Bausch Health in Q1 2016 and held it in 7 quarters.
  • Camber Capital Management's Bausch Health position peaked at $88.4M in Q4 2020.
  • 352 funds tracked by Wall St. Rank held Bausch Health as of Q1 2021.

Based on Camber Capital Management's 13F filing for Q1 2021, filed 17 May 2021.